Latest Breaking News On - Matt hoberman - Page 1 : comparemela.com

Lirum Therapeutics to Present Positive Data on LX-101, a Novel Clinical-Stage Targeted Therapy Demonstrating Potent Preclinical Activity Against Adult and Pediatric IGF-Related Cancers, at the 2024 AACR Annual Meeting

Lirum Therapeutics to Present Positive Data on LX-101, a Novel Clinical-Stage Targeted Therapy Demonstrating Potent Preclinical Activity Against Adult and Pediatric IGF-Related Cancers, at the 2024 AACR Annual Meeting
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesNew yorkMatt hobermanLirum therapeutics incAmerican association for cancer researchSecurities exchangePresent positive dataRelated cancersCancer researchAnnual meetingMonday aprilLirum therapeuticsSecurities actSecurities exchange actRegistration statement

Lirum Therapeutics Participates in the 13th Annual LifeSci Partners Corporate Access Event

Lirum Therapeutics Participates in the 13th Annual LifeSci Partners Corporate Access Event
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesSan franciscoMatt hobermanBeacon grand hotelLirum therapeutics incTherapeutics participatesAnnual lifesci partners corporate accessAnnual lifesci partners corporate access eventLirum therapeuticsSecurities litigation reform act

Lirum Therapeutics Participates In The 13Th Annual Lifesci Partners Corporate Access Event

Lirum Therapeutics Participates In The 13Th Annual Lifesci Partners Corporate Access Event
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesSan franciscoMatt hobermanLirum therapeutics incBeacon grand hotelAnnual lifesci partners corporate access eventLirum therapeuticsSecurities litigation reform act

Lirum Therapeutics Presents Positive Data on LX-101, a

New York, NY, Oct. 31, 2023 (GLOBE NEWSWIRE) Lirum Therapeutics, Inc. (“Lirum”), an innovative clinical-stage biopharmaceutical company focused on the.

New yorkUnited statesMatt hobermanCompany contactLirum therapeutics incConnective tissue oncology societyTissue oncology societyLirum therapeuticsSecurities litigation reform actLirum therapeuticsRx 101

Lirum Therapeutics Presents Positive Data on LX-101, a Novel Clinical-Stage Targeted Therapy, Demonstrating Potent Preclinical Activity Against Pediatric Sarcomas

Lirum Therapeutics Presents Positive Data on LX-101, a Novel Clinical-Stage Targeted Therapy, Demonstrating Potent Preclinical Activity Against Pediatric Sarcomas
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesMatt hobermanCompany contactLirum therapeutics incConnective tissue oncology societyTherapeutics presents positive dataNovel clinical stage targeted therapyTissue oncology societyLirum therapeuticsSecurities litigation reform act